232 related articles for article (PubMed ID: 35481629)
1. Diversity of mechanisms to control bacterial GTP homeostasis by the mutually exclusive binding of adenine and guanine nucleotides to IMP dehydrogenase.
Fernández-Justel D; Marcos-Alcalde Í; Abascal F; Vidaña N; Gómez-Puertas P; Jiménez A; Revuelta JL; Buey RM
Protein Sci; 2022 May; 31(5):e4314. PubMed ID: 35481629
[TBL] [Abstract][Full Text] [Related]
2. The Bateman domain of IMP dehydrogenase is a binding target for dinucleoside polyphosphates.
Fernández-Justel D; Peláez R; Revuelta JL; Buey RM
J Biol Chem; 2019 Oct; 294(40):14768-14775. PubMed ID: 31416831
[TBL] [Abstract][Full Text] [Related]
3. A Nucleotide-Dependent Conformational Switch Controls the Polymerization of Human IMP Dehydrogenases to Modulate their Catalytic Activity.
Fernández-Justel D; Núñez R; Martín-Benito J; Jimeno D; González-López A; Soriano EM; Revuelta JL; Buey RM
J Mol Biol; 2019 Mar; 431(5):956-969. PubMed ID: 30664871
[TBL] [Abstract][Full Text] [Related]
4. The gateway to guanine nucleotides: Allosteric regulation of IMP dehydrogenases.
Buey RM; Fernández-Justel D; Jiménez A; Revuelta JL
Protein Sci; 2022 Sep; 31(9):e4399. PubMed ID: 36040265
[TBL] [Abstract][Full Text] [Related]
5. Guanine nucleotide binding to the Bateman domain mediates the allosteric inhibition of eukaryotic IMP dehydrogenases.
Buey RM; Ledesma-Amaro R; Velázquez-Campoy A; Balsera M; Chagoyen M; de Pereda JM; Revuelta JL
Nat Commun; 2015 Nov; 6():8923. PubMed ID: 26558346
[TBL] [Abstract][Full Text] [Related]
6. A nucleotide-controlled conformational switch modulates the activity of eukaryotic IMP dehydrogenases.
Buey RM; Fernández-Justel D; Marcos-Alcalde Í; Winter G; Gómez-Puertas P; de Pereda JM; Luis Revuelta J
Sci Rep; 2017 Jun; 7(1):2648. PubMed ID: 28572600
[TBL] [Abstract][Full Text] [Related]
7. The CBS subdomain of inosine 5'-monophosphate dehydrogenase regulates purine nucleotide turnover.
Pimkin M; Markham GD
Mol Microbiol; 2008 Apr; 68(2):342-59. PubMed ID: 18312263
[TBL] [Abstract][Full Text] [Related]
8. A novel cofactor-binding mode in bacterial IMP dehydrogenases explains inhibitor selectivity.
Makowska-Grzyska M; Kim Y; Maltseva N; Osipiuk J; Gu M; Zhang M; Mandapati K; Gollapalli DR; Gorla SK; Hedstrom L; Joachimiak A
J Biol Chem; 2015 Feb; 290(9):5893-911. PubMed ID: 25572472
[TBL] [Abstract][Full Text] [Related]
9. IMPDH forms the cytoophidium in zebrafish.
Keppeke GD; Chang CC; Antos CL; Peng M; Sung LY; Andrade LEC; Liu JL
Dev Biol; 2021 Oct; 478():89-101. PubMed ID: 34048735
[TBL] [Abstract][Full Text] [Related]
10. MgATP regulates allostery and fiber formation in IMPDHs.
Labesse G; Alexandre T; Vaupré L; Salard-Arnaud I; Him JL; Raynal B; Bron P; Munier-Lehmann H
Structure; 2013 Jun; 21(6):975-85. PubMed ID: 23643948
[TBL] [Abstract][Full Text] [Related]
11. Insight into the role of the Bateman domain at the molecular and physiological levels through engineered IMP dehydrogenases.
Gedeon A; Ayoub N; Brûlé S; Raynal B; Karimova G; Gelin M; Mechaly A; Haouz A; Labesse G; Munier-Lehmann H
Protein Sci; 2023 Aug; 32(8):e4703. PubMed ID: 37338125
[TBL] [Abstract][Full Text] [Related]
12. Regulation of IMP dehydrogenase gene expression by its end products, guanine nucleotides.
Glesne DA; Collart FR; Huberman E
Mol Cell Biol; 1991 Nov; 11(11):5417-25. PubMed ID: 1717828
[TBL] [Abstract][Full Text] [Related]
13. Post-translational regulation of retinal IMPDH1 in vivo to adjust GTP synthesis to illumination conditions.
Plana-Bonamaisó A; López-Begines S; Fernández-Justel D; Junza A; Soler-Tapia A; Andilla J; Loza-Alvarez P; Rosa JL; Miralles E; Casals I; Yanes O; de la Villa P; Buey RM; Méndez A
Elife; 2020 Apr; 9():. PubMed ID: 32254022
[TBL] [Abstract][Full Text] [Related]
14. A regulatory role of the Bateman domain of IMP dehydrogenase in adenylate nucleotide biosynthesis.
Pimkin M; Pimkina J; Markham GD
J Biol Chem; 2009 Mar; 284(12):7960-9. PubMed ID: 19153081
[TBL] [Abstract][Full Text] [Related]
15. Different characteristics and nucleotide binding properties of inosine monophosphate dehydrogenase (IMPDH) isoforms.
Thomas EC; Gunter JH; Webster JA; Schieber NL; Oorschot V; Parton RG; Whitehead JP
PLoS One; 2012; 7(12):e51096. PubMed ID: 23236438
[TBL] [Abstract][Full Text] [Related]
16. Neurodevelopmental disorder mutations in the purine biosynthetic enzyme IMPDH2 disrupt its allosteric regulation.
O'Neill AG; Burrell AL; Zech M; Elpeleg O; Harel T; Edvardson S; Mor-Shaked H; Rippert AL; Nomakuchi T; Izumi K; Kollman JM
J Biol Chem; 2023 Aug; 299(8):105012. PubMed ID: 37414152
[TBL] [Abstract][Full Text] [Related]
17. Inosine-5'-monophosphate dehydrogenase is required for mitogenic competence of transformed pancreatic beta cells.
Metz S; Holland S; Johnson L; Espling E; Rabaglia M; Segu V; Brockenbrough JS; Tran PO
Endocrinology; 2001 Jan; 142(1):193-204. PubMed ID: 11145582
[TBL] [Abstract][Full Text] [Related]
18. Consequences of IMP dehydrogenase inhibition, and its relationship to cancer and apoptosis.
Jayaram HN; Cooney DA; Grusch M; Krupitza G
Curr Med Chem; 1999 Jul; 6(7):561-74. PubMed ID: 10390601
[TBL] [Abstract][Full Text] [Related]
19. Crystal structure of a ternary complex of Tritrichomonas foetus inosine 5'-monophosphate dehydrogenase: NAD+ orients the active site loop for catalysis.
Gan L; Petsko GA; Hedstrom L
Biochemistry; 2002 Nov; 41(44):13309-17. PubMed ID: 12403633
[TBL] [Abstract][Full Text] [Related]
20. PKB/Akt interacts with inosine-5' monophosphate dehydrogenase through its pleckstrin homology domain.
Ingley E; Hemmings BA
FEBS Lett; 2000 Aug; 478(3):253-9. PubMed ID: 10930578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
